Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3907384
Max Phase: Preclinical
Molecular Formula: C18H21N3O
Molecular Weight: 295.39
Molecule Type: Small molecule
Associated Items:
ID: ALA3907384
Max Phase: Preclinical
Molecular Formula: C18H21N3O
Molecular Weight: 295.39
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN(C(=O)Nc1ccc(C2CCNC2)cc1)c1ccccc1
Standard InChI: InChI=1S/C18H21N3O/c1-21(17-5-3-2-4-6-17)18(22)20-16-9-7-14(8-10-16)15-11-12-19-13-15/h2-10,15,19H,11-13H2,1H3,(H,20,22)
Standard InChI Key: KPVBXXJDPJNOTR-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 295.39 | Molecular Weight (Monoisotopic): 295.1685 | AlogP: 3.43 | #Rotatable Bonds: 3 |
Polar Surface Area: 44.37 | Molecular Species: BASE | HBA: 2 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.95 | CX Basic pKa: 10.90 | CX LogP: 2.39 | CX LogD: -0.35 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.91 | Np Likeness Score: -1.11 |
1. (2016) Substituted benzamides, |
Source(1):